NEW YORK (GenomeWeb) — Asuragen said today that it has received CE marking for its AmplideX DM1 Dx kit for use in the diagnosis of myotonic dystrophy type I (DM1).
DM1, also known as Steinert's disease, is an inherited form of muscular dystrophy characterized by a repeat expansion of 50 CTG trinucleotides or greater in the DMPK gene. According to Asuragen, disease severity positively correlated to the number of repeats, which can extend beyond 1,000.